Kangji Medical Holdings Limited

SEHK:9997 株式レポート

時価総額:HK$6.8b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております!

Kangji Medical Holdings 将来の成長

Future 基準チェック /36

Kangji Medical Holdingsは、14.5%と17.9%でそれぞれ年率14.5%で利益と収益が成長すると予測される一方、EPSはgrowで14.3%年率。

主要情報

14.5%

収益成長率

14.3%

EPS成長率

Medical Equipment 収益成長35.1%
収益成長率17.9%
将来の株主資本利益率n/a
アナリストカバレッジ

Low

最終更新日19 May 2024

今後の成長に関する最新情報

Recent updates

Investors Could Be Concerned With Kangji Medical Holdings' (HKG:9997) Returns On Capital

Apr 12
Investors Could Be Concerned With Kangji Medical Holdings' (HKG:9997) Returns On Capital

Kangji Medical Holdings Limited (HKG:9997) Shares Could Be 32% Above Their Intrinsic Value Estimate

Mar 08
Kangji Medical Holdings Limited (HKG:9997) Shares Could Be 32% Above Their Intrinsic Value Estimate

Kangji Medical Holdings Limited's (HKG:9997) Share Price Not Quite Adding Up

Dec 21
Kangji Medical Holdings Limited's (HKG:9997) Share Price Not Quite Adding Up

Kangji Medical Holdings' (HKG:9997) Returns On Capital Not Reflecting Well On The Business

Oct 23
Kangji Medical Holdings' (HKG:9997) Returns On Capital Not Reflecting Well On The Business

Should You Be Adding Kangji Medical Holdings (HKG:9997) To Your Watchlist Today?

Aug 17
Should You Be Adding Kangji Medical Holdings (HKG:9997) To Your Watchlist Today?

A Look At The Intrinsic Value Of Kangji Medical Holdings Limited (HKG:9997)

Jul 28
A Look At The Intrinsic Value Of Kangji Medical Holdings Limited (HKG:9997)

Kangji Medical Holdings (HKG:9997) Will Be Hoping To Turn Its Returns On Capital Around

May 16
Kangji Medical Holdings (HKG:9997) Will Be Hoping To Turn Its Returns On Capital Around

Is Now The Time To Put Kangji Medical Holdings (HKG:9997) On Your Watchlist?

May 01
Is Now The Time To Put Kangji Medical Holdings (HKG:9997) On Your Watchlist?

Some Shareholders Feeling Restless Over Kangji Medical Holdings Limited's (HKG:9997) P/E Ratio

Apr 13
Some Shareholders Feeling Restless Over Kangji Medical Holdings Limited's (HKG:9997) P/E Ratio

A Look At The Fair Value Of Kangji Medical Holdings Limited (HKG:9997)

Mar 28
A Look At The Fair Value Of Kangji Medical Holdings Limited (HKG:9997)

Here's Why Kangji Medical Holdings (HKG:9997) Has Caught The Eye Of Investors

Jan 03
Here's Why Kangji Medical Holdings (HKG:9997) Has Caught The Eye Of Investors

Are Kangji Medical Holdings Limited (HKG:9997) Investors Paying Above The Intrinsic Value?

Sep 21
Are Kangji Medical Holdings Limited (HKG:9997) Investors Paying Above The Intrinsic Value?

Kangji Medical Holdings (HKG:9997) Is Reinvesting At Lower Rates Of Return

Jun 12
Kangji Medical Holdings (HKG:9997) Is Reinvesting At Lower Rates Of Return

Kangji Medical Holdings' (HKG:9997) Shareholders Will Receive A Bigger Dividend Than Last Year

May 16
Kangji Medical Holdings' (HKG:9997) Shareholders Will Receive A Bigger Dividend Than Last Year

Kangji Medical Holdings (HKG:9997) Will Pay A Larger Dividend Than Last Year At HK$0.17

May 02
Kangji Medical Holdings (HKG:9997) Will Pay A Larger Dividend Than Last Year At HK$0.17

Returns On Capital At Kangji Medical Holdings (HKG:9997) Paint A Concerning Picture

Dec 20
Returns On Capital At Kangji Medical Holdings (HKG:9997) Paint A Concerning Picture

Analysts Just Slashed Their Kangji Medical Holdings Limited (HKG:9997) EPS Numbers

Mar 31
Analysts Just Slashed Their Kangji Medical Holdings Limited (HKG:9997) EPS Numbers

Here's Why We Think Kangji Medical Holdings' (HKG:9997) Statutory Earnings Might Be Conservative

Feb 03
Here's Why We Think Kangji Medical Holdings' (HKG:9997) Statutory Earnings Might Be Conservative

Does Kangji Medical Holdings Limited (HKG:9997) Create Value For Shareholders?

Dec 30
Does Kangji Medical Holdings Limited (HKG:9997) Create Value For Shareholders?

An Intrinsic Calculation For Kangji Medical Holdings Limited (HKG:9997) Suggests It's 42% Undervalued

Nov 25
An Intrinsic Calculation For Kangji Medical Holdings Limited (HKG:9997) Suggests It's 42% Undervalued

業績と収益の成長予測

SEHK:9997 - アナリストの将来予測と過去の財務データ ( )CNY Millions
日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数
12/31/20261,624785N/AN/A1
12/31/20251,345669N/AN/A2
12/31/20241,134569N/AN/A2
12/31/2023926504333420N/A
9/30/2023892540312390N/A
6/30/2023858576291360N/A
3/31/2023822528267340N/A
12/31/2022786479242319N/A
9/30/2022745447261326N/A
6/30/2022704415281332N/A
3/31/2022697436343384N/A
12/31/2021690457405436N/A
9/30/2021654413379405N/A
6/30/2021617369353374N/A
3/31/2021564310278298N/A
12/31/2020511250203221N/A
9/30/2020506227246261N/A
6/30/2020500204290301N/A
3/31/2020502205303313N/A
12/31/2019503206316326N/A
12/31/2018354147189205N/A
12/31/2017248118136143N/A

アナリストによる今後の成長予測

収入対貯蓄率: 9997の予測収益成長率 (年間14.5% ) は 貯蓄率 ( 2.2% ) を上回っています。

収益対市場: 9997の収益 ( 14.5% ) はHong Kong市場 ( 11.7% ) よりも速いペースで成長すると予測されています。

高成長収益: 9997の収益は増加すると予測されていますが、大幅には増加しません。

収益対市場: 9997の収益 ( 17.9% ) Hong Kong市場 ( 7.8% ) よりも速いペースで成長すると予測されています。

高い収益成長: 9997の収益 ( 17.9% ) 20%よりも低い成長が予測されています。


一株当たり利益成長率予想


将来の株主資本利益率

将来のROE: 9997の 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です


成長企業の発掘